13FADMA BIOLOGICS INC (ADMA)
7 tracked managers currently hold ADMA on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | Q2 2026 | ADD | $44.1M | 0.0 % | 0.0 % | 5,274,597 | +4,713,770 |
| Duquesne Family Office LLC | Q2 2026 | ADD | $23.3M | 0.5 % | 0.5 % | 2,784,110 | +1,238,500 |
| TWO SIGMA INVESTMENTS, LP | Q2 2026 | TRIM | $16.9M | 0.0 % | 0.0 % | 2,019,887 | -72,246 |
| CITADEL ADVISORS LLC | Q2 2026 | TRIM | $11.5M | 0.0 % | 0.0 % | 1,370,071 | -4,440,571 |
| MILLENNIUM MANAGEMENT LLC | Q2 2026 | TRIM | $9.7M | 0.0 % | 0.0 % | 1,154,228 | -2,280,221 |
| Point72 Asset Management, L.P. | Q2 2026 | TRIM | $3.5M | 0.0 % | 0.1 % | 413,935 | -2,874,822 |
| Bridgewater Associates, LP | Q2 2026 | TRIM | $3.4M | 0.0 % | 0.0 % | 401,059 | -71,049 |